Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

The Cloud Is Making Oracle Great Again

Oracle has used its dominance in databases to become a power in the cloud, and ORCL stock is rising despite some analyst disdain.

Stuck Below SPAC Price, Astra Space Stock Can Still Get Off the Ground

Traders rushed to dump ASTR stock after a recent highly publicized misfire. However, Astra Space still has solid fundamentals.

Washington Acrimony Hurts the Case for Canopy Growth

While the public may want cannabis legalization, getting the pivotal piece of legalization will be a roadblock for CGC stock.

Senseonics Stock Looks Like It Is Going to Stay Rangebound for a While

It’s a risk to have one company account for much of your revenue. In the case of Senseonics, that’s a good thing for SENS stock. 

Focus On PIF, Not PIPE To See Where Lucid Group Stock Is Headed

Lucid Group saw its share price drop 10% due to a lockup expiry for PIPE shareholders. That’s not the biggest problem facing LCID stock.

Use Recent Rally to Take Profits in Senseonics

Sensesonics has quite a ways to go before reaching commercial success. As such, traders should use run-ups, such as the current one, to trim SENS stock.

Nvidia Is A Growth Stock You Must Not Take Lightly

Nvidia's consistent revenue growth shows its strength in the industry. NVDA stock is poised for massive highs in the near future.

Skillz Stock Is Still Years Away From Its True Payoff Moment

If company-specific stumbles, and/or a market correction, send SKLZ stock down to single digits? Consider it a more than opportune time to buy.

Innovative Hyliion Depends Heavily on a SPAC Revival

Stuck in a funk, HYLN stock needs another boost in the SPAC arena. However, this doesn’t look to be coming anytime soon.

Clover Health Stock Isn’t Going to $20 Anytime Soon, But It Still Might Be a Buy

Clover Health Investments trades near its $9.50 median price target for CLOV stock. Until more analysts buy into its story, caution is key. 

It’s Best to Wait on Baidu Stock in Light of China’s Crackdown

There's a significant chance that Chinese regulators will crack down on Baidu. Therefore, investors should avoid BIDU stock.

It’s OK to Keep Some Chips Off the Table With Lucid Motors

Lucid Motors has ambitious goals that may be delayed until the global chip shortage is resolved. Invest in LCID stock accordingly.

Post-Pandemic Salesforce Stock Emerges as Czar of the ‘Cloudless’ Cloud

Salesforce owns some data centers, but also rents from the Cloud Czars, giving it the footprint of a major cloud player without the cost. CRM stock is down 3% this month.

The Boring Reaction to Gamestop’s Q2 Earnings Is Actually Good News

This year, traders learned to not bet against GME stock. This makes for a bullish thesis. You should be invested in it or waiting to invest.

Pinterest Stock: 2 Reasons To Be Excited and 3 Reasons To Worry

Pinterest is more than a pure social media company, but PINS stock currently has too many fundamental issues for comfort.

Forget GameStop. Buy These 5 Stocks Instead

It's tempting to buy GameStop for big gains. However, for one share of GME stock, you could buy all five of these other stocks.  

Ashford Hospitality Trust: Not the Best Hotel Stock

On the surface, Ashford Hospitality Trust might seem cheap and loaded up with cash. However, AHT stock holds hidden dangers.

BlackBerry Has a Chance at Turning Into a Growth Stock

BlackBerry could turn into a growth stock with more clients and free cash flow next year. BB stock could be worth 30% more at $13.95 per share assuming the company turns FCF positive next fiscal year.

How Novavax Stock Can Rally 30% to New Highs

Now is not the time to bet against NVAX stock. The technicals are strong, while Novavax has strong growth estimates for earnings and revenue.